View New Articles By
CRISPR pioneer, Former Damon Runyon Innovator Feng Zhang, PhD, and colleagues at the Broad Institute and Massachusetts Institute of Technology, have found a new enzyme that can insert custom genes into DNA without first cutting it apart. This method could make future gene editing more accurate and safer for treating a number of diseases by replacing a disease-related gene with a healthy version.
Henry T. Lynch, MD (Damon Runyon Grantee 1969-70), father of cancer genetics, has passed away at age 91, leaving behind a lasting legacy in cancer research and treatment. When Dr. Lynch began his career, most scientists blamed cancer on environmental causes, such as the presence of carcinogenic chemicals and viruses. Hereditary explanations were dismissed, even shunned. His painstaking research putting together family histories established that certain cancers are hereditary. Today genetic screening is an important part of cancer prevention, saving thousands of lives.
The Damon Runyon Cancer Research Foundation honored William M. Raveis, Jr., Chairman and CEO, William Raveis Real Estate, Mortgage & Insurance, for his transformational support and commitment to raising funds and awareness for Damon Runyon.
Mark G. Shrime, MD, PhD, MPH, is a Damon Runyon Clinical Investigator who will compete on the upcoming season of NBC's American Ninja Warrior (Season premieres on Wednesday, May 29 at 8/7c on NBC).
“It is unthinkable that a doctor could tell you that there is nothing that can be done for your child,” says Damon Runyon-Sohn Pediatric Cancer Fellow Kathryn R. Taylor, PhD, of Stanford University School of Medicine. But that is the reality for hundreds of families who are facing a devastating pediatric brain cancer diagnosis called glioma. “We now know that pediatric cancers are not the same as their corresponding adult cancers and may require different treatments. I chose to study the unique biology of pediatric tumors as a developmental disease because it is key to finding effective therapies,” says Kathryn. Her research focuses on how glioma cells use signals in the surrounding brain tissue to promote their own growth.
(Bronx, NY) More than 2,150 people from across the country and abroad took part in the 11th Annual Runyon 5K at Yankee Stadium on Saturday, May 11, 2019, raising nearly $400,000 to support breakthrough cancer research by today’s best young scientists, funded by the Damon Runyon Cancer Research Foundation. Since the inaugural event in 2009, the annual Runyon 5K has raised more than $5.5 million.
(New York, NY) To help increase the number of physician-scientists, the Damon Runyon Cancer Research Foundation created the Damon Runyon Physician-Scientist Training Award, which provides physicians who have earned an MD degree and completed clinical specialty fellowship training the opportunity to gain the research experience they need to become leaders in translational and clinical research. Damon Runyon announced that six scientists with novel approaches to fighting cancer have been named the 2019 recipients of the award.
Guest Author: Marissa Rashkovan, PhD, Damon Runyon-Sohn Pediatric Cancer Fellow
On my 14th birthday, my parents sat my brother and me down and let us know that my mom had cancer – non-Hodgkin’s Lymphoma to be exact. At the time, I didn’t know what that was.
We recently hosted a Twitter chat with Damon Runyon Clinical Investigator, Joshua Brody, MD, of the Icahn School of Medicine at Mount Sinai to discuss his latest breakthrough - a promising new cancer vaccine that activates the immune system to fight tumors throughout the body. While Dr. Brody didn't have the time to answer all the questions about his exciting research during the hour-long Twitter chat, the full interview is presented here.
Damon Runyon Clinical Investigator Priscilla K. Brastianos, MD, is driven to find a cure for metastatic cancer. Dr. Brastianos’s grandmother was 23 years old when she felt a breast mass during medical school training and diagnosed herself with breast cancer, only to pass away at 29 when the cancer had metastasized to the spine. Four decades later, her mother faced the same devastating diagnosis. After living through therapy after therapy that failed, she lost the fight to breast cancer that had metastasized to the brain.
CONNECT
1.877.7CANCER
info@damonrunyon.org
One Exchange Plaza
55 Broadway, Suite 302
New York, NY 10006
